1.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...
by Baigent, Colin, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2181-2192

2.
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
by Li, Jian
The Lancet infectious diseases, 2006, Vol.6 (9), p.589-601

3.
Mechanism of differential control of NMDA receptor activity by NR2 subunits
by GIELEN, Marc
Nature, 2009, Vol.459 (7247), p.703-707

4.
The Tangle or Nuclear Receptors that Controls Xenobiotic Metabolism and Transport : Crosstalk and Consequences
by PASCUSSI, Jean-Marc
Annual review of pharmacology and toxicology, 2008, Vol.48 (1), p.1-32

5.
Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety
by Nohynek, Gerhard J
Critical reviews in toxicology, 2007, Vol.37 (3), p.251-277

6.
Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review
by Gaspar, M. C
European journal of clinical microbiology & infectious diseases, 2013-04-26, Vol.32 (10), p.1231-1252

7.
The Relationship Between Sensory Processing Patterns and Behavioural Responsiveness in Autistic Disorder: A Pilot Study
by Baker, Amy E. Z
Journal of autism and developmental disorders, 2007-09-25, Vol.38 (5), p.867-875

8.
Coeliac disease and the risk of fractures – a general population‐based cohort study
by LUDVIGSSON, J. F.
Alimentary pharmacology & therapeutics, 2007-02, Vol.25 (3), p.273-285

9.
Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis
by Lega, J-C
Thorax, 2009-10, Vol.64 (10), p.869-875

10.
Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle
by Cheng, L
British Journal of Ophthalmology, 2008-05, Vol.92 (5), p.705-711

11.
Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C
by Boursier, J.
Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (2), p.178-188

12.
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs
by DUXIN SUN
Pharmaceutical research, 2002, Vol.19 (10), p.1400-1416

13.
Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort Study
by Poole, Chris D., PhD
Clinical therapeutics, 2013, Vol.35 (1), p.40-51

14.
The T cell factor/β-Catenin Antagonist PKF115–584 Inhibits Proliferation of Adrenocortical Carcinoma Cells
by Doghman, Mabrouka
The journal of clinical endocrinology and metabolism, 2008-08, Vol.93 (8), p.3222-3225

15.
Orexigenic Neuropeptide 26RFa: New Evidence for an Adaptive Profile of Appetite Regulation in Anorexia Nervosa
by Galusca, Bogdan
The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2012-2018

16.
Severe gastro‐oesophageal reflux symptoms in relation to anxiety, depression and coping in a population‐based study
by JANSSON, C.
Alimentary pharmacology & therapeutics, 2007-09, Vol.26 (5), p.683-691

17.
Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models
by LUNDQUIST, Stefan
Pharmaceutical research, 2002, Vol.19 (7), p.976-981

18.
Natural history of gastro‐oesophageal reflux disease diagnosed in general practice
by Ruigómez, A.
Alimentary pharmacology & therapeutics, 2004-10, Vol.20 (7), p.751-760

19.
Long-lasting improved amino acid bioavailability associated with protein pulse feeding in hospitalized elderly patients: A randomized controlled trial
by Bouillanne, Olivier, M.D., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2014, Vol.30 (5), p.544-550

20.
Risk factors for inflammatory bowel disease in the general population
by GARCÍA RODRÍGUEZ, L. A.
Alimentary pharmacology & therapeutics, 2005-08, Vol.22 (4), p.309-315
